- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02939963
Ventilation Strategies During Spontaneous Breathing Trial (WEANING)
Comparison of Two Ventilatory Modes During Spontaneous Breathing Trial in Intubated Patients
Patients who are intubated and mechanically ventilated for acute respiratory failure in the Intensive Care Unit (ICU) are at some point eligible for weaning. The common way to wean them from mechanical ventilation is to screen criteria for feasibility and, if present, to test feasibility by performing spontaneous breathing trial. This latter can be done either by setting a low pressure support level (expected to compensate the airflow resistance due to endotracheal tube) or by allowing the patient to breathe spontaneously through the tube without any support from the ventilator. Combination of low pressure assistance strategy (7 cm H2O) and positive expiratory pressure (PEP) of 4 cm H2O is the strategy used in our unit. Such a low pressure support level should actually result in a real assistance and, hence this is not the real spontaneous breathing capacity that is tested. Some ICU ventilators offer the option of compensating for the airflow resistance due to endotracheal tube, automatic tube compensation (ATC). Therefore, investigators aimed at comparing in patients ready to wean the usual procedure in our ICU and the ATC mode. In the ATC arm, the patients are breathing spontaneously through the endotracheal tube and are connected to the ventilator set at inspiratory pressure support of 0 cm H2O, PEP 4 cm H2O and ATC on.
Two parallel arms depending on the order of allocation of each mode: pressure support 7 cm H2O + PEP 4 cm H2O then ATC or the opposite. The primary endpoint is the power of the work of breathing. The hypothesis is that the power of the work of breathing is greater in ATC than in the usual procedure, and hence this latter is a real ventilator support.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lyon, France, 69004
- Hôpital de la Croix Rousse
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age 18 years or more
- intubated and mechanically ventilated for at least 24 consecutive hours
- staying in the medical ICU at the Croix Rousse Hospital, Lyon, France
- pressure support ventilation 10-15 cm H2O, total respiratory rate 25-35 breaths/min, expired tidal volume 6-8 ml/kg predicted body weight
- meeting criteria for spontaneous breathing trial (able to answer simple questions, no ongoing intravenous sedation, norepinephrine ≤ 1 mg/H, dobutamine ≤ 20 mg/h, fraction of inspired oxygen (FIO2 ≤ 50%), PEP ≤ 5 cm H2O, respiratory rate ≤ 35 breaths/min, saturation in oxygen (SpO2) ≥88%)
- under Dräger Evita XL ou V500 ICU ventilator
- agreement to participate from the patient or next of kin
Exclusion Criteria:
- Chronic respiratory failure under long term home oxygen therapy and/or non invasive ventilation before ICU admission
- Tracheotomy
- nasogastric tube contra-indicated
- thoracic tube in place
- no agreement to participate
- under justice protection
- deprived of freedom
- pregnant or breastfeeding
- not affiliated to social insurance
- involved into another study that may interfere with present study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ATC then pressure support 7 cm H2O PEP 4 cm H2O
spontaneous breathing through endotracheal tube with no ventilator support except for ATC
|
spontaneous breathing through endotracheal tube with no ventilator support except for ATC, the patient is connected to the ventilator with pressure support 0 cm H2O and PEP 4 cm H2O during 30 minutes then 30 minutes of basal pressure support then 30 minutes with pressure support 7 cm H2O PEP 4 cm H2O
|
|
Experimental: pressure support 7 cm H2O PEP 4 cm H2O then ATC
ventilator is set to pressure support ventilation mode at set pressure 7 cm H2O above PEEP level of 4 cm H2O
|
30 minutes with pressure support 7 cm H2O PEP 4 cm H2O then 30 minutes of basal pressure support then 30 minutes with spontaneous breathing through endotracheal tube with no ventilator support except for ATC, the patient is connected to the ventilator with pressure support 0 cm H2O and PEP 4 cm H2O
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the power of work of breathing
Time Frame: 30 minutes after onset the ventilator strategy
|
the work of breathing is measured from the area subtended by the esophageal pressure - lung volume relationship.
The power of work of breathing is obtained by multiplying work of breathing by the respiratory frequency and expressed in Joules/min
|
30 minutes after onset the ventilator strategy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory rate
Time Frame: 30 minutes
|
the respiratory rate is measured from the airflow tracing
|
30 minutes
|
|
tidal volume
Time Frame: 30 minutes
|
integration of airflow over time during expiration
|
30 minutes
|
|
intrinsic PEP
Time Frame: 30 minutes
|
deflection in esophageal pressure up to the first zero flow
|
30 minutes
|
|
occlusion pressure at 100 ms
Time Frame: 30 minutes
|
measured from the airway pressure at the first 100 ms after airway occlusion
|
30 minutes
|
|
work of breathing per liter
Time Frame: 30 minutes
|
work of breathing normalized for 1 liter tidal volume
|
30 minutes
|
|
Distribution of pulmonary ventilation
Time Frame: 30 minutes
|
distribution of pulmonary ventilation will be measured by the Pulmovista system
|
30 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Claude Guerin, Pr, Hôpital de la Croix-Rousse
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL16_0411
- 2016-A01172-49 (Other Identifier: ANSM Number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Respiratory Insufficiency
-
Clinical Hospital Center RijekaNot yet recruitingAcute Respiratory InsufficiencyCroatia
-
GCS Ramsay Santé pour l'Enseignement et la RechercheNot yet recruiting
-
Yolanda Lopez FernandezHospital Infantil Universitario Niño Jesús, Madrid, Spain; Dr. Negrin University... and other collaboratorsRecruitingAcute Respiratory InsufficiencySpain
-
Dr. Negrin University HospitalAsociación Científica Pulmón y Ventilación Mecánica; Consorcio Centro de Investigación...CompletedAcute Respiratory InsufficiencySpain
-
Dr. Negrin University HospitalConsorcio Centro de Investigación Biomédica en Red, M.P.; Asociación Científica...CompletedAcute Respiratory InsufficiencyUnited Kingdom
-
Hospital del Mar Research Institute (IMIM)Hospital Universitari de Bellvitge; Instituto de Salud Carlos III; Hospital Universitari... and other collaboratorsNot yet recruitingAcute Hypoxemic Respiratory FailureSpain
-
University Hospital, ToursNot yet recruiting
-
Ain Shams UniversityCompletedAcute Hypoxemic Respiratory FailureEgypt
-
Prof RWABIHAMA Jean PaulNot yet recruitingAcute Hypoxemic Respiratory FailureRwanda
-
Lorenzo delSorboRoche Diagnostic Ltd.RecruitingAcute Hypoxemic Respiratory FailureCanada
Clinical Trials on ATC then pressure support 7 cm H2O PEP 4 cm H2O
-
Advanced Circulatory SystemsU.S. Army Medical Research and Development CommandTerminated
-
inSleep Technologies, LLCJohns Hopkins University; Doctors Community Hospital; NeuroTrials Research, Inc.CompletedSnoringUnited States